EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer. uri icon

Overview

publication date

  • June 1, 2005

Identity

Scopus Document Identifier

  • 21344455131

Digital Object Identifier (DOI)

  • 10.1038/ncponc0200

PubMed ID

  • 16264986

Additional Document Info

volume

  • 2

issue

  • 6